It has been demonstrated that serum level of IL-8 was significantly high and commonly associated with the enhanced clinical course, a higher tumor grade, and the presence of liver or lymph node involvement in high-grade breast cancer patients. This evidence concerns the gene CXCL8 and breast carcinoma.